Introduction Research should be one of the pillars of a resilient flexible health system,1 and building research capacity is crucial for maintaining or improving quality of care and patient outcomes.  Translational research is an important phase of the research process.  Allied Health professionals (AHP) comprise a significant and vital proportion of the Australian healthcare workforce across several professional categories.  Such personnel are uniquely placed to design, generate, and execute clinically meaningful research, and translate it into practice.2,3 However, the literature

IntroductionReal-world outcomes of acute myeloid leukaemia (AML) are poor compared to the results of clinical trials.  This partially reflects population differences due to patient selection criteria in trials (excluding older and unfit patients who are unsuitable for aggressive treatment), and lack of improvement in the efficacy of intensive chemotherapy over time.  However, there have been successful developments in AML management including improved non-intensive therapies, laboratory diagnostics to stratify patient risk, donor selection for allogeneic stem cell transplantation (allo-SCT) and supportive

IntroductionDiffuse idiopathic skeletal hyperostosis (DISH), also known as Forestier’s disease or ankylosing hyperostosis, is a common skeletal disorder, which is reported to range in frequency from 3.8% of males and 2.6% of females in a Finnish population-based study to 22.4% of males and 13.4% of females in an Israeli hospital-based study.1, 2 The disorder was first described by Forestier, Jacqueline and Rotes-Querol in 1950.3  The skeletal phenotype suggests it is an historically ancient disorder, but the pathophysiology is still poorly

IntroductionPatients infected with SARS-CoV-2 (COVID-19 disease) present with respiratory tract infection and symptoms such as fever, cough, fatigue, sputum production and/or breathlessness.1 The spectrum of COVID-19 varies from asymptomatic infection through mild upper respiratory tract illness, to severe and potentially fatal viral pneumonia with respiratory failure. The Chinese Centre for Disease Control and Prevention reported that 70,420 of the 80,928 confirmed cases in China are “cured and discharged from hospital,” while 3,245 have died.2  However, in the early stage of